Clinical Trials Logo
  1. Home
  2. MRI
  3. NCT05261724
  4. Details
NCT05261724 Clinical Trial

Diffusion-tensor Imaging in Brain Tumors Evaluation

MRI Clinical Trial

Official title:
Contribution of Diffusion Tensor Imaging and Tractography in Primary and Secondary Brain Tumors Evaluation

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05261724
Other study ID # GEPaladeU
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 15, 2021
Est. completion date March 14, 2022

Study information
Verified date February 2022
Source George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Contact Mihail Porutiu
Phone +40722694996
Email mihai.nobel@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Primary and secondary brain tumors are challenging pathologies regarding diagnosis and treatment. MRI is widely used in the imaging evaluation and surgical planning, due to its spatial resolution and ability of tissular characterization. In this study patients with suspected brain tumors, confirmed by routine MRI evaluation (T1, T2, T2*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation. By analyzing collected data from MRI evaluation and patient records regarding surgical and histopathological data our aim is to investigate derived imaging biomarkers with impact in the surgical planning and rehabilitation of the patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date March 14, 2022
Est. primary completion date March 14, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - brain tumors confirmed by routine MRI evaluation - surgical treatment with histopathological diagnosis Exclusion Criteria: - MRI contraindications - past or present neurological or neurosurgical condition, beside the tumor - pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• MRI
In this study patients with suspected primary and secondary brain tumors, confirmed by routine MRI evaluation (T1, T2, T2*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation.

Locations
Country Name City State
Romania SCJU Mures Targu Mures Mures

Sponsors (1)
Lead Sponsor Collaborator
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures

Country where clinical trial is conducted

Romania, 

Outcome
Type Measure Description Time frame Safety issue
Primary Tract damage Assess the damage of tracts at baseline preoperative 3 months
Secondary Craniotomy size Assess the size of craniotomy in patients with postoperative CT follow-up 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05036629 - Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects N/A
Completed NCT02548819 - University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices N/A
Completed NCT01168479 - FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer Phase 3
Completed NCT00512226 - Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia N/A
Recruiting NCT05439330 - Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning N/A
Not yet recruiting NCT05464576 - Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis N/A
Recruiting NCT04028375 - Study of CT and MR in the Gastric Cancer
Recruiting NCT04034667 - Study of CT and MR in the Lung Cancer
Recruiting NCT04231175 - Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer N/A
Completed NCT00949507 - Comparison of Two Regimens of Anesthesia for Children Undergoing Magnetic Resonance Imaging (MRI) in General Anesthesia Phase 4
Completed NCT01420211 - Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® Phase 1/Phase 2
Recruiting NCT05167669 - Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFU Early Phase 1
Recruiting NCT05618990 - OPTIMIZATION of ADVANCED MR SEQUENCES
Recruiting NCT05107232 - OSV-IRM - Volunteer MRI Sequence Optimization N/A
Completed NCT00556101 - Patient Acceptance of Whole Body Magnetic Resonance Angiography N/A
Recruiting NCT03142698 - Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis N/A
Suspended NCT00554073 - Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T N/A
Completed NCT06366906 - 10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
Not yet recruiting NCT05359497 - Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis N/A
Recruiting NCT05192629 - Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging Phase 3